Literature DB >> 4064450

Effect of plasma exchange on the steady-state kinetics of digoxin and digitoxin.

F Keller, G Kreutz, H F Vöhringer, G Offermann, A Distler.   

Abstract

The pharmacokinetic effect of extracorporeal elimination can be evaluated from the extracorporeal elimination rate constant, from the amount of drug removed, and from extracorporeal clearance. To compare the validity of these approaches in clinical practice, the effect of multiple plasma exchanges on the steady-state kinetics of digoxin (5 patients) and digitoxin (9) was investigated. For digoxin, an unchanged elimination half-life (28 hours) and only slight increase in the total body clearance was found (from 203 to 204 ml/min). There was a more pronounced effect on the kinetics of digitoxin, where the elimination half-life decreased from 4.3 to 3.6 days, and the total body clearance increased from 4.4 to 4.7 ml/min. For digoxin there was no statistically significant difference between observed and predicted steady-state trough plasma concentrations. For digitoxin, the observed trough plasma concentrations at steady-state correlated well (p less than 0.05) with the predicted concentrations calculated from the amount removed or from extracorporeal clearance. The magnitude of the kinetic effect of plasma exchange is overestimated using the extracorporeal elimination rate constant; but the effect of extracorporeal elimination can be adequately evaluated from the amount of drug removed and from extracorporeal clearance. These later approaches can be considered model-independent. Thus, the influence of multiple plasma exchanges on the steady-state kinetics of digoxin and digitoxin will be limited and dosage adjustment is not required, if these drugs are given after - not before - the procedure and hypoalbuminaemia is corrected.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4064450     DOI: 10.2165/00003088-198510060-00004

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  15 in total

1.  Pharmacokinetics of digoxin in normal subjects after intravenous bolus and infusion doses.

Authors:  J R Koup; D J Greenblatt; W J Jusko; T W Smith; J Koch-Weser
Journal:  J Pharmacokinet Biopharm       Date:  1975-06

2.  Drug kinetics and artificial kidneys.

Authors:  T B Gibson; H A Nelson
Journal:  Clin Pharmacokinet       Date:  1977 Nov-Dec       Impact factor: 6.447

3.  Kinetic modeling: applications in renal and related diseases.

Authors:  P C Farrell
Journal:  Kidney Int       Date:  1983-10       Impact factor: 10.612

4.  Kinetic modeling of hemodialysis, hemofiltration, and hemodiafiltration.

Authors:  K B Sprenger; W Kratz; A E Lewis; U Stadtmüller
Journal:  Kidney Int       Date:  1983-08       Impact factor: 10.612

5.  Pharmacokinetic effects of altered plasma protein binding of drugs in renal disease.

Authors:  F Keller; M Maiga; H H Neumayer; H Lode; A Distler
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1984 Jul-Sep       Impact factor: 2.441

6.  Control of dialysis by a single-pool urea model: the National Cooperative Dialysis Study.

Authors:  J A Sargent
Journal:  Kidney Int Suppl       Date:  1983-04       Impact factor: 10.545

7.  Membrane plasma exchange by single-needle hemofiltration device. A technical note.

Authors:  H Wilms; F Keller; G Offermann
Journal:  Int J Artif Organs       Date:  1984-07       Impact factor: 1.595

8.  Pharmacokinetic considerations in exchange transfusion in neonates.

Authors:  G J Yakatan; R B Smith; R D Leff; J L Kay
Journal:  Clin Pharmacol Ther       Date:  1978-07       Impact factor: 6.875

9.  Removal of prednisone and prednisolone by plasma exchange.

Authors:  W H Stigelman; D H Henry; R L Talbert; R J Townsend
Journal:  Clin Pharm       Date:  1984 Jul-Aug

Review 10.  Protein binding of cardiac glycosides in disease states.

Authors:  L Storstein
Journal:  Clin Pharmacokinet       Date:  1977 May-Jun       Impact factor: 6.447

View more
  4 in total

Review 1.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

2.  Kinetics of ceftazidime during plasmapheresis.

Authors:  F Bozkurt; P Schollmeyer; E Keller
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 3.  Age-related differences in digoxin toxicity and its treatment.

Authors:  T G Wells; R A Young; G L Kearns
Journal:  Drug Saf       Date:  1992 Mar-Apr       Impact factor: 5.606

4.  Pharmacokinetics of ceftriaxone during plasma exchange in polyarteritis nodosa patients.

Authors:  F Fauvelle; O Lortholary; M Tod; L Guillevin; M Louchahi; A Léon; O Petitjean
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.